Vbi Vaccines Inc (VBIV) CEO, President Jeff Baxter Bought $105,120 of Shares (Guru Focus)
CEO, President of Vbi Vaccines Inc (NASDAQ:VBIV) Jeff Baxter bought 144,000 shares of VBIV on 06/19/2019 at an average price of $0.73 a share. The total cost of this purchase was $105,120. VBI Vaccines Inc is a biopharmaceutical company. It is engaged in developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI Vaccines Inc has a market cap of $77.160 million; its shares were traded at around $0.79 with and P/S ratio of 15.80. VBI Vaccines Inc had annual average EBITDA growth of 8.90% over the past five years.
Wednesday 6/19 Insider Buying Report: CHWY, NBR (Nasdaq.com)
At Chewy (CHWY), a filing with the SEC revealed that on Tuesday, Director Raymond Svider purchased 60,000 shares of CHWY, for a cost of $22.00 each, for a total investment of $1.32M. Svider was up about 71.0% on the purchase at the high point of today’s trading session, with CHWY trading as high as $37.63 in trading on Wednesday. Chewy is trading off about 6% on the day Wednesday. This purchase marks the first one filed by Svider in the past year. And at Nabors Industries (NBR), there was insider buying on Friday, by Chief Financial Officer William J. Restrepo who purchased 177,100 shares at a cost of $2.03 each, for a total investment of $359,065. Nabors Industries is trading up about 6.7% on the day Wednesday. So far Restrepo is in the green, up about 18.9% on their purchase based on today’s trading high of $2.41.
Insider Activity: Intra-Cellular Therapies (ITCI) Board Member Buys $2 Million in Stock (Investors Observer)
Christopher D Alafi, a member of the board of directors at Intra-Cellular Therapies (ITCI), bought 170,000 shares of the company’s common stock on Jun 12. At $11.73 per share, Alafi paid a total of $1,993,793 for the new shares.
What Did This CEO Just Do with Personal Shares of EKSO BIONICS (NASDAQ: EKSO)? (Analyst Ratings)
Today, the CEO of EKSO BIONICS (EKSO), Jack Peurach, sold shares of EKSO for $43.07K. In addition to Jack Peurach, 2 other EKSO executives reported Sell trades in the last month. Based on EKSO BIONICS’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $3.62 million and GAAP net loss of $6.55 million.
The President & COO of Stryker Corporation (NYSE: SYK) is Selling Shares (Analyst Ratings)
Today, the President & COO of Stryker Corporation (SYK), Timothy Scannell, sold shares of SYK for $922.4K. Following Timothy Scannell’s last SYK Sell transaction on May 17, 2019, the stock climbed by 14.0%. Based on Stryker Corporation’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $3.52 billion and quarterly net profit of $412 million.
